Company Profile
Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, listed on the Hong Kong Stock Exchange, stock code: 0455) implements the following development strategies: development of Traditional Chinese medicine (“TCM”) as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services. It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.
Tianda Pharmaceuticals forges the entire TCM industrial chain from Chinese medicine, Chinese Medicinal herbs to the application of artificial intelligence in TCM. It has established the "Tianda standard", a Chinese medicinal herbs quality control standard, and the modern Chinese medicine clinic - TDMall. As a TCM treatment and health management platform, TDMall practices TCM by adhering to the philosophy that “a great physician treats an illness before it develops”, following the treatment principle of “medication should be stopped once its efficacy shows and treatment should be centred on the patient”. Based in the Guangdong-Hong Kong-Macau Greater Bay Area, TDMall applies domestic and international strategic business plan and strives to develop into the leading brand of Chinese medicine clinic. Making full use of Internet information technology, big data, artificial intelligence and other innovative technologies, Tianda Pharmaceuticals has built "TDMall on Cloud" to implement the integration of online and offline TCM services, remote diagnosis and treatment and expert consultation, which provides a high-quality, convenient and comprehensive TCM health services for the general public, becoming a forerunner in the promotion of TCM inheritance, innovation and development.

Latest News
Press Releases
-
02.02.2021
TDMall enters community and organizes The "Anti-Epidemic Formula ...
Press Releases
- 11.12.2020
Sustainability Strategy
- 10.12.2020
Sustainability Strategy
- 20.11.2020
Sustainability Strategy
-
09.10.2020
Tianda Pharmaceuticals received an award for sustainable developm ...
Press Releases
-
09.10.2020
Tianda Pharmaceuticals received an award for sustainable developm ...
Sustainability Strategy
- 28.09.2020
Media Coverage
-
03.08.2020
Tianda Pharmaceuticals Plans to Launch 100 TDMalls and Explores N ...
Tianda for Health!


T i a n d a f o r H e a l t h !
Core Business
Achievements



Shares and Details
Announcements & Circulars
- 02.02.2021
- 05.01.2021
-
16.12.2020
Announcements and Notices - [Major Transaction / Termination of Transaction] TERMINATION OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR